Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs

Black Country
17 January 2014 11:46



North and East Yorks and North Lincs
17 January 2014 11:49


Exclusive vacancies may not be shown here, please contact Mark on +44 1494 818 049 or markd@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Mark Denton
Managing Director
markd@zenopa.com
+44 1494 818 049

Testimonials
I have been working through a contract with Zenopa since March 2012. I actually find this approach more beneficial to me as I have someone independent from the company who I can talk to about any issu...
Jennifer, 2012

Takeda joins Structural Genomics Consortium

5 April 2012 00:00 in Pharmaceutical Company Product News


Takeda has become a member of the Structural Genomics Consortium (SGC) in order to support innovative pharmaceutical research across the world.

The healthcare firm will support the not-for-profit organisation - which is based at the Universities of Toronto and Oxford - in funding collective drug research and bringing new medicines to market more rapidly.

Six of the world's leading pharmaceutical businesses are now contributing to this project, up from three over the previous four years, while the amount of available funding has jumped to $50 million (31.5 million pounds).

More than 200 scientists are involved in the scheme, which will provide early-stage research freely available to the wider community with no patent restrictions.

Paul Chapman, general manager for the pharmaceutical research division at Takeda, said: "We ... firmly believe that important new medicines will be discovered in industry and vital scientific knowledge will be gained in academia through this open innovation."

Last week, the company announced the establishment of a new global headquarters structure, in order to better align with its expanding international profile.ADNFCR-8000103-ID-801334651-ADNFCR

Other news stories from 05/04/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd